ALC-0159
ALC-0159, a polyethylene glycol (PEG) lipid conjugate, could be used as vaccine excipient[1].
Product Specifications
CAS Number
1849616-42-7
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Liposome
Type
Oligonucleotides
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/alc-0159.html
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic) |Ethanol : ≥ 50 mg/mL
Smiles
CCCCCCCCCCCCCCN(C(COCCOC)=O)CCCCCCCCCCCCCC.[n]
Molecular Formula
(C2H4O) nC31H63NO2
Precautions
H302, H315, H319, H335
References & Citations
[1]S Moein Moghimi, et al. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Mol Ther. 2021 Mar 3;29 (3) :898-900.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041845-500 1x 500 µL
Aurora B (Proliferation Marker) (AURKB/1845), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details